AEMD (STOCKS)
AETHLON MEDICAL INC
$2.120000
-0.080000 (-3.64%)
Prev close: $2.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James B. Frakes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.02M
- Employees
- 9
- P/E (TTM)
- -0.04
- P/B (TTM)
- 0.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q2)
|
$-3.74 | $-3.74 | -0.0034 | -0.09% |
|
Jun 2025 (Q1)
|
$-8.50 | $-8.77 | +0.2720 | +3.10% |
|
Mar 2025 (Q4)
|
$-79.70 | $-10.30 | -69.3980 | -673.64% |
|
Dec 2024 (Q3)
|
$-10.40 | $-17.41 | +7.0077 | +40.26% |
Financial Statements
| Revenues | -$90.18K |
| Operating Expenses | $7.12M |
| Research and Development | $2.33M |
| Other Operating Expenses | $4.79M |
| Operating Income/Loss | -$7.12M |
| Income/Loss From Continuing Operations After Tax | -$11.26M |
| Income/Loss From Continuing Operations Before Tax | -$11.26M |
| Net Income/Loss | -$11.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $20.92 |
| Diluted Earnings Per Share | $20.92 |
| Basic Average Shares | 1,731,855 |
| Diluted Average Shares | 1,731,855 |
| Assets | $7.32M |
| Current Assets | $6.25M |
| Noncurrent Assets | $1.07M |
| Fixed Assets | $513.99K |
| Other Non-current Assets | $555.22K |
| Liabilities | $1.58M |
| Current Liabilities | $1.40M |
| Accounts Payable | $570.79K |
| Other Current Liabilities | $834.21K |
| Noncurrent Liabilities | $172.12K |
| Equity | $5.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.75M |
| Liabilities And Equity | $7.32M |
| Net Cash Flow From Operating Activities | -$7.06M |
| Net Cash Flow From Operating Activities, Continuing | -$7.06M |
| Net Cash Flow From Investing Activities | $994.64K |
| Net Cash Flow From Investing Activities, Continuing | $969.34K |
| Net Cash Flow From Financing Activities | $6.09M |
| Net Cash Flow From Financing Activities, Continuing | $6.09M |
| Exchange Gains/Losses | -$25.30K |
| Net Cash Flow | $25.30K |
| Net Cash Flow, Continuing | $50.60K |
| Comprehensive Income/Loss | -$11.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.27M |
| Other Comprehensive Income/Loss | -$10.19K |